Q2 EPS Estimates for H.B. Fuller Raised by Seaport Res Ptn

H.B. Fuller (NYSE:FULFree Report) – Stock analysts at Seaport Res Ptn upped their Q2 2025 earnings per share estimates for shares of H.B. Fuller in a research note issued on Wednesday, March 26th. Seaport Res Ptn analyst M. Harrison now forecasts that the specialty chemicals company will post earnings of $1.00 per share for the quarter, up from their previous estimate of $0.99. Seaport Res Ptn has a “Hold” rating on the stock. The consensus estimate for H.B. Fuller’s current full-year earnings is $4.07 per share. Seaport Res Ptn also issued estimates for H.B. Fuller’s Q3 2025 earnings at $1.14 EPS, FY2025 earnings at $3.73 EPS, Q2 2026 earnings at $1.21 EPS, Q3 2026 earnings at $1.34 EPS, Q4 2026 earnings at $1.40 EPS and FY2026 earnings at $4.62 EPS.

H.B. Fuller (NYSE:FULGet Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The specialty chemicals company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.49 by $0.05. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The business had revenue of $788.66 million during the quarter, compared to the consensus estimate of $769.55 million. During the same quarter in the prior year, the firm earned $0.67 EPS. The firm’s quarterly revenue was down 2.7% on a year-over-year basis.

A number of other brokerages also recently weighed in on FUL. JPMorgan Chase & Co. lowered their price target on H.B. Fuller from $60.00 to $50.00 and set an “underweight” rating on the stock in a report on Friday. Deutsche Bank Aktiengesellschaft lowered their target price on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a research note on Wednesday, January 22nd. Vertical Research lowered shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. Finally, Citigroup lowered their price objective on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $70.00.

Get Our Latest Report on H.B. Fuller

H.B. Fuller Price Performance

Shares of NYSE:FUL opened at $54.76 on Friday. The company’s fifty day moving average is $58.31 and its two-hundred day moving average is $68.75. The company has a market cap of $2.97 billion, a P/E ratio of 23.70, a price-to-earnings-growth ratio of 1.13 and a beta of 1.41. H.B. Fuller has a 12-month low of $52.59 and a 12-month high of $87.67. The company has a quick ratio of 1.16, a current ratio of 1.81 and a debt-to-equity ratio of 1.10.

H.B. Fuller Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, February 20th. Stockholders of record on Thursday, February 6th were paid a dividend of $0.2225 per share. This represents a $0.89 dividend on an annualized basis and a dividend yield of 1.63%. The ex-dividend date was Thursday, February 6th. H.B. Fuller’s dividend payout ratio (DPR) is presently 38.53%.

Institutional Investors Weigh In On H.B. Fuller

Institutional investors have recently made changes to their positions in the company. Jones Financial Companies Lllp raised its holdings in shares of H.B. Fuller by 128.8% during the 4th quarter. Jones Financial Companies Lllp now owns 899 shares of the specialty chemicals company’s stock valued at $61,000 after purchasing an additional 506 shares in the last quarter. Sterling Capital Management LLC increased its position in H.B. Fuller by 731.1% during the fourth quarter. Sterling Capital Management LLC now owns 1,255 shares of the specialty chemicals company’s stock worth $85,000 after buying an additional 1,104 shares during the last quarter. MetLife Investment Management LLC raised its holdings in H.B. Fuller by 4.7% during the fourth quarter. MetLife Investment Management LLC now owns 33,058 shares of the specialty chemicals company’s stock valued at $2,231,000 after buying an additional 1,472 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of H.B. Fuller in the fourth quarter worth about $266,000. Finally, Wesbanco Bank Inc. boosted its stake in shares of H.B. Fuller by 41.2% during the 4th quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after acquiring an additional 4,000 shares in the last quarter. 95.93% of the stock is currently owned by institutional investors and hedge funds.

H.B. Fuller Company Profile

(Get Free Report)

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.

See Also

Earnings History and Estimates for H.B. Fuller (NYSE:FUL)

Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.